Redefining women's health.

Gameto is a female-led biotech company developing treatment solutions to improve women's reproductive health throughout their lives: from egg freezing, infertility, and diseases of the reproductive years to menopause and conditions that occur afterward.

We are building treatment solutions to provide better options for women. 

Women's reproductive health is an underdeveloped area within the healthcare industry.

Despite a growing global infertility crisis, female reproductive therapies have remained largely unimproved since inception decades ago.

Until now.

We’ve developed a platform that is broadly applicable and has the potential to solve many gaps in the women’s health space. Our first focus is filling the massive gaps in the fertility space.

Creating transformative solutions for women’s health

The first application of our technology aims to improve the current IVF and egg freezing landscape. We are advancing technology in a space that has been virtually untouched since inception.

Scientists, Innovators, and Biotechnology Entrepreneurs

Our female-led team understands the burden women take when embarking on their reproductive journeys and is passionate about improving it. Our mission to redefine women's health guides everything we do.

Find out how to join us.

Latest news

News

Gameto lands ARPA-H funding to combat menopause with cell therapy

News

Gameto Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

News

Gameto Presents New Data on In Vitro Maturation Product Candidate Fertilo During Seven Presentations at the 2024 American Society for Reproductive Medicine (ASRM) Annual Meeting

News

Gameto Selected for Seven Presentations at the American Society for Reproductive Medicine (ASRM) 2024 Annual Meeting

News

Gameto Appoints Dr. Jaime Knopman as Chairwoman of Clinical Advisory Board to Guide Clinical Strategy and Innovation in Women’s Health

News

Gameto Appoints Dr. Ghassan (Gus) Haddad as Chief Medical Officer to Lead Clinical Development of Fertilo, a Cell-Based Treatment for IVF and Egg Freezing

News

Dawn of the Silicon Valley Superbaby

News

Gameto Presents Data Supporting Manufacturing Process for its In Vitro Maturation Solution for Fertility Care at 2024 International Society for Stem Cell Research Annual Meeting

News

Gameto Presents Advances in Assisted Reproductive Technology at 2024 European Society of Human Reproduction and Embryology Annual Meeting

News

Blog Post: Fertility Treatments for the New Age

News

Gameto Secures $33M To Support Clinical Development of Fertility Treatment

News

Gameto Secures $33M in Series B Funding to Advance Novel In Vitro Fertilization Treatments

News

Gameto Raises $33M to Use Cell Engineering to Revolutionize Fertility Treatments

News

Gameto lands $33 million to advance women’s reproductive health

News

Gameto Raises $33 Million in Series B Financing to Advance Development and Commercialization of Novel Fertility Treatments

News

New York startup raises $33M for fertility treatment based on George Church’s stem cell research

News

Gameto Partners with Designer and Entrepreneur Stacey Bendet to Launch "Your Eggsperience Matters" Campaign to Raise Funds for RESOLVE During National Infertility Awareness Week

Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments

News

Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation

News

The next frontier in baby-making: More successful IVF, egg cells from men, and sperm cells from women? Biotech researchers aim to greatly expand reproductive opportunity.

News

Gameto Unveils New Data on In Vitro Maturation Product Candidate Fertilo During Four Presentations at the 2023 American Society for Reproductive Medicine

News

Gameto CEO Dr. Dina Radenkovic Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit

News

This biotech CEO decided to take her own (fertility) medicine

News

Gameto inks stem cell deal with Reprocell for female fertility program

REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs

News

What if We Could Get Rid of Menopause?

News

Gameto Named as 2023 Technology Pioneer by World Economic Forum

News

The Future of Fertility: A new crop of biotech startups want to revolutionize human reproduction.

News

Fertility treatments, closer to becoming cheaper?

News

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

News

Reimagining Infertility – An Interview with Christian Kramme

News

Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University

News

Why it is key to anticipate to preserve fertility?

News

A healthcare brand for women begins to take shape

News

Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women's Health

News

Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine

News

34 of the most promising women's health startups of 2022, according to VCs

News

Gameto, the biotech startup that uses cell engineering to treat with ovarian deterioration, arrives in Spain

News

Varsavsky chooses Madrid for the preclinical studies in Europe of his startup Gameto

News

Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics

News

Biotech Startup Gameto on Female Fertility and Aging

News

Gameto, the startup that seeks to delay menopause, lands in Spain

News

Is it Time to Cancel Menopause?

News

The 20(+1) under 40: Your guide to the next generation of biotech leaders

News

Why aren’t VCs funding more startups focused on menopause?

News

International Women’s Day: the wonderful women of longevity

News

Gameto founder talks menopause and female healthspan extension

News

Nature Is Sexist. Can Advances In Longevity Biotechnology Help Restore Reproductive Equality?

News

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells

Scientific Publications

An integrated pipeline for mammalian genetic screening